Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2009-12-18 Director's Dealing
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2009-12-18 English
Major Shareholding Notification 2009
Major Shareholding Notification
2009-12-18 English
DECEMBER 16, 2009 EQUITY 11 TRANCHE
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated December 18, 2009. It reports an unregistered sale of equity securities (Convertible Preferred Shares) and details about the transaction and securities involved. There are no financial statements or exhibits included, and the document is focused on reporting a specific equity transaction event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is 4232 characters, which is consistent with a typical 8-K filing for such an event. Therefore, the appropriate classification is CAP with high confidence.
2009-12-18 English
FIRST AMENDMENT TO CONVERTIBLE PREFERRED SECURITIES AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated December 18, 2009. It announces the execution of a First Amendment to a Convertible Preferred Securities Agreement, which is a material definitive agreement related to financing. The content focuses on an amendment to a securities agreement and does not contain financial statements or detailed financial performance data. The document length is 2959 characters, which is relatively short and primarily serves as an announcement of a financing agreement amendment. Therefore, it fits best under Capital/Financing Update (CAP) as it updates on company financing activities.
2009-12-18 English
S-1 WITHDRAWL REQUEST
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the SEC requesting the withdrawal of a Pre-Effective Amendment No. 3 to a Registration Statement on Form S-1. It references regulatory rules (Rule 477 under the Securities Act of 1933) and discusses procedural matters related to the withdrawal of a filing. The document does not contain financial statements or substantive financial data but is a regulatory communication about a filing withdrawal. The document length is short (1780 characters), and it is clearly an announcement/request related to regulatory filings rather than a financial report or detailed filing itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory communications that do not fit other specific categories.
2009-12-09 English
DECEMBER 4, 2009 $65K TRANCHE
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated December 8, 2009. It reports an unregistered sale of equity securities (Convertible Preferred Shares) and details about the transaction and related agreements. There are no financial statements or exhibits attached, and the document is relatively short (4207 characters). The content focuses on a financing transaction rather than a full financial report or earnings release. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). This is not an announcement of a report publication, nor is it a certification or regulatory fallback. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2009-12-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.